FDA.reportPublic FDA data

Insulizen

Manufacturer
HCBIOPHARM LLC
Effective date
2026-03-30
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
full-release
Hydrated at
2026-06-01 02:38:12

Label at a glance#

ProductInsulizen
Active ingredientLAGERSTROEMIA SPECIOSA LEAF, MORINDA CITRIFOLIA FRUIT
Label structure9 sections

Dosage and administration

Take two (2) capsules daily 1 hour before breakfast.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Lagerstroemia speciosa Leaf 1X, Morinda citrifolia Fruit 1X

Purpose

OTC - PURPOSE SECTION

Reduces insulin resistance, restores defective insulin receptors, and maintains a normal blood sugar level*

Keep Out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

Directions

DOSAGE & ADMINISTRATION SECTION

Take two (2) capsules daily 1 hour before breakfast.

Use

INDICATIONS & USAGE SECTION

  • To reduce insulin resistance
  • To restore defective insulin receptors
  • To maintain a normal blood sugar level

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Turmeric (Curcuma longa), Eucommia (Eucommia ulmoides) Bark, White Mulberry (Morus alba) Root Bark, Bitter Melon (Momordica charantia) Fruit, Red Sage (Salvia miltiorrhiza) Root

Warning

WARNINGS SECTION

Individuals with known medical conditions should consult a doctor prior to using this.

Other Information

OTHER SAFETY INFORMATION

Do not use if seal is broken.
Do not eat freshness packet enclosed.
Keep product out of direct sunlight, high temperature, and humidity.
Store in a cool, dry place.

Package Label Display

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Insulizen

INSULIN RESISTANCE REDUCER
INSULIN RECEPTOR RESTORE
BLOOD SUGAR LEVEL BALANCE

Homeopathic 60 Capsules
insulizeninsulizen

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
80353-451-01Insulizen1 in 1 BOXCAPSULE16
80353-451-02Insulizen1 in 1 BOTTLECAPSULE16
80353-451-03Insulizen60 in 1 CAPSULECAPSULE606

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
80353-45180353-451-03, 80353-451-02, 80353-451-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
NameUNIIKind
LAGERSTROEMIA SPECIOSA LEAFOUK5B3W9E4ACTIB
MORINDA CITRIFOLIA FRUIT7829X3G2X5ACTIB
CURCUMA LONGA WHOLEW5488JUO8UIACT
EUCOMMIA ULMOIDES BARKL878N1L0ARIACT
MORUS ALBA ROOT BARKSV6B76DK9NIACT
MOMORDICA CHARANTIA FRUITUA63Y8U89UIACT
SALVIA MILTIORRHIZA ROOT1693AM5SBNIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
InsulizenINSULIN RESISTANCE REDUCER, INSULIN RECEPTOR RESTORE, AND BLOOD SUGAR LEVEL BALANCEHCBIOPHARM LLCd10353a9-0543-831e-e053-2a95a90a4e912026-03-30WarningsExact identifier
ndc (package): 80353-451-01
ndc (package): 80353-451-03
ndc (package): 80353-451-02
ndc (product): 80353-451
ndc11 (package): 80353045103
ndc11 (package): 80353045101
ndc11 (package): 80353045102
spl id: 4e3805b9-f7bf-4d36-e063-6294a90a51ff
spl set id: d10353a9-0543-831e-e053-2a95a90a4e91

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.